Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Sep 28, 2021 7:58pm
223 Views
Post# 33934976

RE:RE:RE:Liminal Update

RE:RE:RE:Liminal UpdateNailed this one...money in way ahead of some poster(s) predictions and guess what, no frciken bridge loan required!

Anxious to see which indications they will pursue with the money.

The company anticipates using the proceeds to be received by Liminal to advance the continued development of our small molecule pipeline, and we plan to update the market regarding our small molecules R&D strategy in the coming months following the review of the complete data from the ongoing fezagepras phase 1 multi-ascending dose clinical trial.

Also, cash burn should be considerably lower with the divesture of the Ryplazim program.




aldo451 wrote: Forgot to add that if R&D spending would resume when voucher money received, this likely means that the money is in!

aldo451 wrote: New job posting: Animal Health Technician

Guess someone suggested they move ahead with their pre-clinical programs. Shop ain't closing just yet!

balain wrote:
This happened on Wednesday morning...

1- There was an employee meeting called by management where employees were told that there would be no R&D spending until the voucher money was received.
 
2- The company said that it had no specific R&D projects at this time.
 
3- They also solicited the scientific team (at least what is left of it) to make suggestions if they had any...
 
This ship is currently dead in the water...

balain

 




<< Previous
Bullboard Posts
Next >>